Early lung cancer detection, mucosal, and alveolar imaging

Alejandro H. Sardi, Shaheen Islam

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Purpose of review Lung cancer is the leading cause of cancer deaths worldwide. Early detection is essential for long-term survival. Screening of high-risk individuals with low-dose computed tomography screening has proven to increase survival. However, current radiological imaging techniques have poor specificity for lung cancer detection and poor sensitivity for detection of mucosal or alveolar preinvasive malignant lesions. Bronchoscopy allows imaging and sampling of early lung cancer, with the highest safety profile and high diagnostic accuracy. Recent findings Available technologies, such as autofluorescence bronchoscopy, narrow band imaging, and radial ultrasound bronchoscopy can significantly increase the yield and diagnostic accuracy of bronchoscopy for early cancer detection in the central airways. Newer technologies such as optical coherence tomography, confocal bronchoscopy, and Raman spectroscopy may significantly increase the diagnostic yield of both central and parenchymal early cancer lesions. Summary Although some of these technologies are still investigational and are not readily available in most centers, they may identify early mucosal and alveolar cancer lesions accurately in the least invasive manner to provide appropriate therapy and prolong patient survival from lung cancer.

Original languageEnglish (US)
Pages (from-to)271-280
Number of pages10
JournalCurrent Opinion in Pulmonary Medicine
Volume22
Issue number3
DOIs
StatePublished - May 1 2016
Externally publishedYes

Fingerprint

Bronchoscopy
Early Detection of Cancer
Lung Neoplasms
Technology
Survival
Narrow Band Imaging
Neoplasms
Raman Spectrum Analysis
Optical Coherence Tomography
Cause of Death
Tomography
Safety

Keywords

  • bronchoscopy
  • confocal bronchoscopy
  • early detection of lung cancer
  • mucosal and alveolar imaging
  • optical coherence tomography

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Early lung cancer detection, mucosal, and alveolar imaging. / Sardi, Alejandro H.; Islam, Shaheen.

In: Current Opinion in Pulmonary Medicine, Vol. 22, No. 3, 01.05.2016, p. 271-280.

Research output: Contribution to journalReview article

@article{e6a3c7e8c80040109b85052e41052e97,
title = "Early lung cancer detection, mucosal, and alveolar imaging",
abstract = "Purpose of review Lung cancer is the leading cause of cancer deaths worldwide. Early detection is essential for long-term survival. Screening of high-risk individuals with low-dose computed tomography screening has proven to increase survival. However, current radiological imaging techniques have poor specificity for lung cancer detection and poor sensitivity for detection of mucosal or alveolar preinvasive malignant lesions. Bronchoscopy allows imaging and sampling of early lung cancer, with the highest safety profile and high diagnostic accuracy. Recent findings Available technologies, such as autofluorescence bronchoscopy, narrow band imaging, and radial ultrasound bronchoscopy can significantly increase the yield and diagnostic accuracy of bronchoscopy for early cancer detection in the central airways. Newer technologies such as optical coherence tomography, confocal bronchoscopy, and Raman spectroscopy may significantly increase the diagnostic yield of both central and parenchymal early cancer lesions. Summary Although some of these technologies are still investigational and are not readily available in most centers, they may identify early mucosal and alveolar cancer lesions accurately in the least invasive manner to provide appropriate therapy and prolong patient survival from lung cancer.",
keywords = "bronchoscopy, confocal bronchoscopy, early detection of lung cancer, mucosal and alveolar imaging, optical coherence tomography",
author = "Sardi, {Alejandro H.} and Shaheen Islam",
year = "2016",
month = "5",
day = "1",
doi = "10.1097/MCP.0000000000000270",
language = "English (US)",
volume = "22",
pages = "271--280",
journal = "Current Opinion in Pulmonary Medicine",
issn = "1070-5287",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Early lung cancer detection, mucosal, and alveolar imaging

AU - Sardi, Alejandro H.

AU - Islam, Shaheen

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Purpose of review Lung cancer is the leading cause of cancer deaths worldwide. Early detection is essential for long-term survival. Screening of high-risk individuals with low-dose computed tomography screening has proven to increase survival. However, current radiological imaging techniques have poor specificity for lung cancer detection and poor sensitivity for detection of mucosal or alveolar preinvasive malignant lesions. Bronchoscopy allows imaging and sampling of early lung cancer, with the highest safety profile and high diagnostic accuracy. Recent findings Available technologies, such as autofluorescence bronchoscopy, narrow band imaging, and radial ultrasound bronchoscopy can significantly increase the yield and diagnostic accuracy of bronchoscopy for early cancer detection in the central airways. Newer technologies such as optical coherence tomography, confocal bronchoscopy, and Raman spectroscopy may significantly increase the diagnostic yield of both central and parenchymal early cancer lesions. Summary Although some of these technologies are still investigational and are not readily available in most centers, they may identify early mucosal and alveolar cancer lesions accurately in the least invasive manner to provide appropriate therapy and prolong patient survival from lung cancer.

AB - Purpose of review Lung cancer is the leading cause of cancer deaths worldwide. Early detection is essential for long-term survival. Screening of high-risk individuals with low-dose computed tomography screening has proven to increase survival. However, current radiological imaging techniques have poor specificity for lung cancer detection and poor sensitivity for detection of mucosal or alveolar preinvasive malignant lesions. Bronchoscopy allows imaging and sampling of early lung cancer, with the highest safety profile and high diagnostic accuracy. Recent findings Available technologies, such as autofluorescence bronchoscopy, narrow band imaging, and radial ultrasound bronchoscopy can significantly increase the yield and diagnostic accuracy of bronchoscopy for early cancer detection in the central airways. Newer technologies such as optical coherence tomography, confocal bronchoscopy, and Raman spectroscopy may significantly increase the diagnostic yield of both central and parenchymal early cancer lesions. Summary Although some of these technologies are still investigational and are not readily available in most centers, they may identify early mucosal and alveolar cancer lesions accurately in the least invasive manner to provide appropriate therapy and prolong patient survival from lung cancer.

KW - bronchoscopy

KW - confocal bronchoscopy

KW - early detection of lung cancer

KW - mucosal and alveolar imaging

KW - optical coherence tomography

UR - http://www.scopus.com/inward/record.url?scp=84961226325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961226325&partnerID=8YFLogxK

U2 - 10.1097/MCP.0000000000000270

DO - 10.1097/MCP.0000000000000270

M3 - Review article

VL - 22

SP - 271

EP - 280

JO - Current Opinion in Pulmonary Medicine

JF - Current Opinion in Pulmonary Medicine

SN - 1070-5287

IS - 3

ER -